Sequential whole bladder photodynamic therapy treatments: A preclinical study

Urologic Oncology

Volumn 3, Issue 1, 1997, Pages 27-30

  Nseyo, Uniyime O ^a,b   Kim, Henry ^b   DeBord, Joe ^b   Tate, Karen ^b   DeHaven, Jean ^b  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Bladder cancer; Detrusor; Dogs; Photosensitizing agent; Phototherapy

Indexed keywords

PHOTOFRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CANCER; CANCER SURGERY; CONTROLLED STUDY; CYSTECTOMY; CYSTOSCOPY; DOG; FEMALE; HISTOPATHOLOGY; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

EID: 0030668927     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-1439(97)00018-5     Document Type: Article

References (25)

1. Dougherty TJ. Photosensitization of malignant tumors. Sem Surg Onc 1986;2:24-37.
2. Nseyo UO. Photodynamic therapy. Urol Clin of N Am 1992;19: 591-9.
3. Hisazumi H, Misaki T, Miyoshi N. Photoradiation therapy of bladder tumors. J Urol 1983;130:685-7.
4. Ohi T, Tsuchiya A. Superficial bladder tumors. In: Hayata Y, Dougherty TJ (eds). Lasers and Hematoporphyrin in Cancer. Tokyo: Igaku-shoin, 1983;79-84.
5. Prout GR, Lin CW, Benson R, Nseyo UO, Daly JJ, Griffin PP, et al. Photodynamic therapy with Hpd in the treatment of superficial transitional cell carcinoma of the bladder. N Engl J Med 1987;317:1251-5.
6. Benson RC, Jr. Treatment of bladder cancer with hematoporphyrin derivatives and laser light. Urology 1988;31(2):13-7.
7. Shumaker BP, Hetzel FW. Clinical laser photodynamic therapy in the treatment of bladder carcinoma. Photochem Photobiol 1987;46(5):899-901.
8. Jocham D, Beer M, Baumgartner R, Staehler G, Unsold E. Long-term experience with integral photodynamic therapy of TIS bladder carcinoma. Ciba Found Symp 1989;146:198-2.
9. D'Hallewin MA, Baert L. Long-term results of whole bladder wall photodynamic therapy for carcinoma-in-situ of the bladder. Urology 1995;45:763-7.
10. Manyak MJ, Cole JW, McNellis RJ, Smith PD. Downstaging of BCG-resistant carcinoma-in-situ of the bladder by photodynamic therapy with intravesical diffusion medium [abstract]. Part 2. J Urol 992:147:374A.
11. Kreigmair M, Waidelich R, Lumper W, Ehsan A, Baumgartner R, Hofstetter A. Integral photodynamic therapy treatment of refractory superficial bladder cancer. J Urol 1995;154:1339-41.
12. Nseyo UO, Crawford ED, Shumaker BP, Hoodin AO, Jewitt M. Huben R, et al. Photodynamic therapy (PDT) as alternative treatment for refractory carcinoma in situ (RCIS). American Association of Cancer Research Annual Meeting, March 18-22, 1995, Toronto, Ontario, Canada.
13. Dugan M, Crawford E, Nseyo U, Shumaker B, Aledia F, Hoodin A, et al. Photodynamic therapy (PDT) after transurethral resection (TUR) for superficial papillary bladder cancer (SBC): A randomized trial [abstract]. Proc Am Soc Clin Oncol 1991; 10:173(554).
14. Harty JI, Amin M, Weiman TJ, Tseng MT, Ackerman D, Broghamen W. Complications of whole bladder dihematoporphyrin ether photodynamic therapy. J Urol 1989;141:1341-6.
15. Nseyo UO, DeBord J, Kim JH, Gebrosky N, Traynelis C, Lamm DL, et al. Optimum light and Photofrin® dose in whole bladder photodynamic therapy (WBPDT) [abstract #131]. IPA Biennial Meeting, September 20-25, 1994, Amelia Island, FL.
16. Nseyo UO, Dougherty TJ, Potter WR, Boyle DG. A study of the factors mediating the effect of photodynamic therapy on bladder using canine bladder mode. Urol 1988;32:44-5.
17. Nseyo UO, Dougherty TJ, Boyle DG, Potter W, Englander LS, Huben RP, et al. Experimental hematoporphyrin derivative photoradiation on canine bladder. J Urol 1985;133:311-5.
18. Nseyo UO, Whalen RK, Lundahl SL. Canine bladder response to red and green light whole bladder photodynamic therapy. Urol 1993:41:292-6.
19. Henderson BW, Dougherty TJ. How does photodynamic therapy work? Photochem Photobiol 1992;55:145-57.
20. Selman SH, Keck RW, Klaunig J, Kreimer-Birnbaum J, Godblatt PJ, Britton SL. Acute blood flow changes in transplantable FANFT-induced urothelial tumors treated with hematoporphyrin in derivative and light. Surg Forum 1983; 34:676.
21. Reed MW, Schuschke DA, Ackerman DM, Harty JI, Wieman TJ, Miller FW. The response of the rat urinary bladder microcirculation to photodynamic therapy. J Urol 1989;142: 865-8.
22. Nseyo UO, Whalen RL, Lundahl SL. Urinary cytokines following photodynamic therapy for bladder cancer: A preliminary report. Urol 1990;36:167.
23. Nseyo UO, Dougherty TJ, Sullivan L. Photodynamic therapy in the management of resistant lower tract urinary cancer. Cancer 1987:60:3113-9.
24. Potter WR, Mang TS, Dougherty TJ. The theory of photodynamic therapy dosimetry: Consequences of photodestruction of sensitizer. Photochem Photobiol 1987;46:97-101.
25. Moan J, McGhie JB, Christensen T. Hematoporphyrin derivatives: Photosensitizing efficiency and cellular uptake of its components. Photochem Photobiol 1982;4:337.